Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines

Japanese Journal of Cancer Research

Volumn 87, Issue 8, 1996, Pages 824-830

  Akama, Yoshihiko ^a,b   Yasui, Wataru ^b   Kuniyasu, Hiroki ^b   Yokozaki, Hiroshi ^b   Akagi, Morihisa ^b   Tahara, Hidetoshi ^b   Ishikawa, Takenori ^a   Tahara, Eiichi ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

CDK; CDK inhibitors; Cell cycle; Cyclin; Gastric carcinoma cells

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0029790215     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb02106.x     Document Type: Article

References (51)

1. Hunter, T. and Pines, J. Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell, 79, 573-582 (1994).
2. Sherr, C. J. Mammalian G1 cyclins. Cell, 73, 1059-1065 (1993).
3. Jiang, W., Kahn, C. M., Tomita, N., Zhang, Y.-J., Lu, S. H. and Weinstein, I. B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52, 2980-2983 (1992).
4. Kitahara, K., Yasui, W., Kuniyasu, H., Yokozaki, H., Akama, Y., Yunotani, S., Hisatsugu, T. and Tahara, E. Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas. Int. J. Cancer, 62, 25-28 (1995).
5. Nishida, N., Fukuda, Y., Komeda, T., Kita, R., Sando, T., Furukawa, M., Amenomori, M., Shibagaki, I., Nakao, K., Ikenaga, M. and Ishizaki, K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res., 54, 3107-3110 (1994).
6. Burkley, M. F., Sweeny, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., deFazio, A., Watts, C. K. W., Musgrove, E. A. and Sutherland, R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127-2133 (1993).
7. Akama, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Kitahara, K., Ishikawa, T. and Tahara, E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res., 86, 617-621 (1995).
8. cdc2 and its kinase activity in human gastric and colonic carcinomas. Int. J. Cancer, 43, 36-41 (1993).
9. Noda, A., Ning, Y., Venable, S. F., P.-Smith, O. M. and Smith, J. R. Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211, 90-98 (1994).
10. E.-Deiry, W. S., Tokino, T., Velcuescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
11. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. The p21 cdk-interacting protein cip 1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell, 75, 805-816 (1993).
12. Polyak, K., Lee, M-H., E.-Bromage, H., Koff, A., Roberts, J. M., Tempst, P. and Massague, J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66 (1994).
13. Toyoshima, H. and Hunter, T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell, 78, 67-74 (1994).
14. Kamb, A., Gruis, N. A., W.-Feldbaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E. and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
15. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K. and Carson, D. A. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756 (1994).
16. Waga, S., Hannon, G. J., Beach, D. and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 369, 574-578 (1994).
17. ser-arg polymorphism of the WAF-1/CIP1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese. Cancer Epidemiol. Biomarkers Prev., 4, 261-267 (1995).
18. Koopman, J., Maintz, D., Schild, S., Schramm, J., Louis, D. N., Wiestler, O. D. and Deimling, A. V. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours. Br. J. Cancer, 72, 1230-1233 (1995).
19. Bhatia, K., Fan, S., Spangler, G., Weintraub, M., O'Connor, P. M., Judde, J.-G. and Magrath, I. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. Cancer Res., 55, 1431-1435 (1995).
20. Tahara, E. Genetic alterations in human gastrointestinal cancers: the application to molecular diagnosis. Cancer, 75S, 1410-1417 (1995).
21. Mattar, R., Yokozaki, H., Yasui, W., Ito, H. and Tahara, E. p53 gene mutations in gastric cancer cell lines. Oncology (Life Sci. Adv.), 11, 7-12 (1992).
22. Yokozaki, H., Kuniyasu, H., Kitadai, Y., Nishimura, K., Todo, H., Ayhan, A., Yasui, W., Ito, H. and Tahara, E. p53 point mutations in primary human gastric carcinomas. J. Cancer Res. Clin. Oncol., 119, 67-70 (1992).
23. Ayhan, A., Yasui, W., Yokozaki, H., Ito, H. and Tahara, E. Genetic abnormalities and expression of p53 in human colon carcinomas. Int. J. Oncol., 1, 431-437 (1992).
24. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22 (1994).
25. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55, 1211-1214 (1995).
26. Kawamata, N., Morosetti, R., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilczynski, S., Lee, Y. Y., Bartram, C. R. and Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269 (1995).
27. Morosetti, R., Kawamata, N., Gombart, A. F., Miller, C. W., Hatta, Y., Hirama, T., Said, J. W., Tomonaga, M. and Koeffler, H. P. Alterations of the p27Kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/ lymphoma. Blood, 86, 1924-1930 (1995).
28. Serrano, M., Hannon, G. J. and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366, 704-707 (1993).
29. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature, 371, 257-260 (1994).
30. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S. and Nakamura, Y. Frequent somatic mutation of the MTS1/ CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
31. Lukas, J., Parry, D., Agaard, L., Mann, D. J., Bartkova, J., Straus, M., Peters, G. and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by tumour suppressor p16. Nature, 375, 503-506 (1995).
32. Koh, J., Enders, G. H., Dynlacht, B. D. and Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375, 506-510 (1995).
33. Ochiai, A., Yasui, W. and Tahara, E. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1. Jpn. J. Cancer Res., 76, 1064-1071 (1985).
34. Yanagihara, K., Seyama, T., Tsumuraya, M., Kamada, N. and Yokoro, K. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res., 51, 381-386 (1991).
35. Yoshida, K., Yokozaki, H., Niimoto, M., Ito, H., Ito, M. and Tahara, E. Expression of TGF-β and procollagen type I and type III in human gastric carcinomas. Int. J. Cancer, 44, 394-398 (1989).
36. Wang, J., Chenivesse, X., Henglein, B. and Brechot, C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature, 343, 555-557 (1990).
37. Lew, D. J., Dulic, V. and Reed, S. I. Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast. Cell, 66, 1197-1206 (1991).
38. Tsai, L.-H., Harlow, E. and Meyerson, M. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature, 353, 174-177 (1991).
39. Akagi, M., Yasui, W., Akama, Y., Yokozaki, H., Tahara, H., Haruma, K., Kajiyama, G. and Tahara, E. Inhibition of cell growth by transforming growth factor β1 is associated with p53-independent induction of p21 in gastric carcinoma cells. Jpn. J. Cancer Res., 87, 377-384 (1996).
40. Bates, S., Bonetta, L., MacAllan, D., Parry, D., Holder, A., Dickson, C. and Peters, G. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene, 9, 71-79 (1994).
41. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. and Givol, D. Induction of Waf1/CIP1 by a p53-independent pathway. Cancer Res., 54, 3391-3395 (1994).
42. Elbendary, A., Berchuck, A., Davis, P., Havrilesky, L., Bast, R. C. and Igrehart, J. D. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ., 5, 1301-1307 (1994).
43. CIPI/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82, 675-684 (1995).
44. Spruck, C. H. I., G.-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M.-F., Gonzales, F., Tsai, Y. C. and Jones, P. A. p16 gene in uncultured tumours. Nature, 370, 183-184 (1994).
45. Zhang, S. Y., K.-Szanto, A. J., Sauter, E. R., Shafarenko, M., Mitsunaga, S., Nobori, T., Carson, D. A., Ridge, J. A. and Goodrow, T. L. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54, 5050-5053 (1994).
46. Merlo, A., Herman, J. G., Lee, D. J., Garbrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692 (1995).
47. G.-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Tornout, J. M. V. and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues with gene silencing. Cancer Res., 55, 4531-4535 (1995).
48. Otterson, G. A., Kratzke, R. A., Coxon, A., Kim, Y. W. and Kaye, F. J. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wild type Rb. Oncogene, 9, 3375-3378 (1994).
49. Yeager, T., Stadler, W., Belair, C., Puthenveettil, J., Olopade, O. and Reznikoff, C. Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res., 55, 493-497 (1995).
50. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81, 323-330 (1995).
51. Kitahara, K., Yasui, W., Yokozaki, H., Semba, S., Hamamoto, T., Hisatsugu, T. and Tahara, E. Expression of cyclin Dl, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. J. Exp. Ther. Oncol., 1, 7-12 (1996).